The stock of Medical Properties Trust Inc (NYSE: MPW) has decreased by -2.44 when compared to last closing price of 4.09. Despite this, the company has experienced a -1.48% fall in its stock price over the last five trading sessions. Seeking Alpha reported 2024-04-13 that Medical Properties Trust saw a spike in shares after announcing a significant update that will allow the company to pay down a large portion of its debt. The company sold off its interest in five hospitals in Utah, receiving $886 million and reducing its debt. The company has already achieved 80% of its $2 billion target for asset sales this year, with potential for further debt reduction.
Is It Worth Investing in Medical Properties Trust Inc (NYSE: MPW) Right Now?
The stock has a 36-month beta value of 1.24. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 2 as “overweight,” 5 as “hold,” and 2 as “sell.”
The public float for MPW is 587.00M, and at present, short sellers hold a 35.20% of that float. On April 15, 2024, the average trading volume of MPW was 20.18M shares.
MPW’s Market Performance
MPW stock saw a decrease of -1.48% in the past week, with a monthly decline of -9.73% and a quarterly a decrease of 13.03%. The volatility ratio for the week is 4.44%, and the volatility levels for the last 30 days are 5.62% for Medical Properties Trust Inc (MPW). The simple moving average for the past 20 days is -6.33% for MPW’s stock, with a -28.85% simple moving average for the past 200 days.
Analysts’ Opinion of MPW
Many brokerage firms have already submitted their reports for MPW stocks, with Colliers Securities repeating the rating for MPW by listing it as a “Neutral.” The predicted price for MPW in the upcoming period, according to Colliers Securities is $4.25 based on the research report published on April 10, 2024 of the current year 2024.
Exane BNP Paribas, on the other hand, stated in their research note that they expect to see MPW reach a price target of $6. The rating they have provided for MPW stocks is “Outperform” according to the report published on March 01st, 2024.
Deutsche Bank gave a rating of “Sell” to MPW, setting the target price at $2 in the report published on January 30th of the current year.
MPW Trading at -0.23% from the 50-Day Moving Average
After a stumble in the market that brought MPW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.85% of loss for the given period.
Volatility was left at 5.62%, however, over the last 30 days, the volatility rate increased by 4.44%, as shares sank -5.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +28.71% upper at present.
During the last 5 trading sessions, MPW fell by -1.48%, which changed the moving average for the period of 200-days by -56.77% in comparison to the 20-day moving average, which settled at $4.25. In addition, Medical Properties Trust Inc saw -18.74% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for MPW
Current profitability levels for the company are sitting at:
- 0.5 for the present operating margin
- 0.63 for the gross margin
The net margin for Medical Properties Trust Inc stands at -0.63. The total capital return value is set at 0.03. Equity return is now at value -6.88, with -2.94 for asset returns.
Based on Medical Properties Trust Inc (MPW), the company’s capital structure generated 0.57 points at debt to capital in total, while cash flow to debt ratio is standing at 0.05.
Currently, EBITDA for the company is 684.64 million with net debt to EBITDA at 24.68. When we switch over and look at the enterprise to sales, we see a ratio of 14.12. The receivables turnover for the company is 1.28for trailing twelve months and the total asset turnover is 0.05.
Conclusion
To sum up, Medical Properties Trust Inc (MPW) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
